相关实验视频

Updated: May 22, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

铁和非编码RNA:探索肺癌治疗中的机制

Nadi Rostami Ravari¹, Farzad Sadri^2,3, Mohammad Ali Mahdiabadi⁴

¹Department of Animal Science Researches, Agriculture and Natural Resources Education and Research Center of Kerman, Agriculture and Natural Resources Education and Research Organization (AREEO), Kerman, Iran.

Frontiers in cell and developmental biology

|March 13, 2025

概括

非编码RNAs (ncRNAs) 是铁亡的关键调节者,这是一种细胞死亡过程,对肺癌 (LC) 治疗至关重要. 了解它们的双重作用提供了新的治疗策略,以准LC的进展和抵抗.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

肺癌 (LC) 是癌症相关死亡的主要原因,由复杂的分子机制驱动.
铁,一种依赖于铁的细胞死亡途径,越来越多地被认为对LC发育和治疗反应的作用.
非编码RNAs (ncRNAs),包括microRNAs (miRNAs) 和长非编码RNAs (lncRNAs),是细胞过程的关键调节者,并与癌症生物学有关.

研究的目的:

审查目前对ncRNAs如何调节肺癌中铁亡的理解.
探索ncRNAs对LC进展,转移和治疗耐药性的影响.
为了确定基于ncRNA介导的铁灭诱导用于LC治疗的潜在治疗策略.

主要方法:

对研究ncRNAs,铁亡和肺癌的文献综述.
分析ncRNAs调节铁亡途径的分子机制.
综合了关于ncRNAs在促进或抑制LC中的ferroptosis的双重作用的发现.

主要成果:

ncRNAs通过向关键基因和参与铁代谢,脂质过氧化和细胞死亡的途径,显著影响铁亡.
已经确定了特定的ncRNAs,它们可以促进或抑制铁亡,影响LC的瘤生长,入侵和耐药性.
在ncRNAs和ferroptosis之间的相互作用为新的治疗干预提供了机会.

结论:

ncRNAs在调节肺癌中的铁亡中发挥着复杂的双重作用.
准ncRNA介导的铁亡途径有望为开发肺癌创新治疗方法提供希望.
对铁亡中的ncRNA功能进行进一步的研究可能会为LC患者改善治疗结果.

关键词:

铁性化 (ferroptosis) 是一种肺癌是一种肺癌.转移转移转移转移没有编码的RNAs.治疗目标是治疗的目标.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...